Company Filing History:

12 out of 1,627

University of Southern California

Years Active: 1988-2010

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7776828 - Radiation therapy methods (2010-08-17),

2. 7745411 - Methods for promoting erythropoiesis (2010-06-29),

3. 7744927 - Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation (2010-06-29),

4. 7338938 - Methods for treating a patient undergoing chemotherapy (2008-03-04),

5. 7176183 - Methods for treating and preventing damage to mucosal tissue (2007-02-13),

6. 7118748 - Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation (2006-10-10),

7. 7022675 - Wound healing compositions (2006-04-04),

8. 6821953 - Methods for treating and preventing damage to mucosal tissue (2004-11-23),

9. 6730775 - Methods for limiting scar and adhesion formation (2004-05-04),

10. 6455501 - Wound healing compositions (2002-09-24),

11. 6335195 - Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation (2002-01-01),

12. 4889722 - Method for inhibiting post-surgical adhesion formation by the topical (1989-12-26),

13. 4764502 - Intragonadal regulatory protein (1988-08-16),

14. 4734398 - Follicular regulating protein (1988-03-29),

Title: The Innovative Contributions of Gere S diZerega

Introduction

Gere S diZerega is a notable inventor based in Pasadena, California, recognized for his significant contributions to the field of medical technology. With a total of 14 patents to his name, diZerega has focused on developing innovative methods that enhance the effectiveness of radiation therapy and promote cell proliferation.

Latest Patents

Among his latest patents, diZerega has introduced groundbreaking methods for mitigating radiation-induced tissue damage. These methods aim to improve the effectiveness of radiation therapy, support bone marrow transplantation, and promote the production and mobilization of megakaryocytes and platelets. The invention involves the administration of effective amounts of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments, angiotensin II (AII), AII analogues, and AII AT-type 2 receptor agonists. Additionally, he has developed methods and improved cell culture mediums for promoting hematopoietic and mesenchymal cell proliferation and differentiation. This innovation also utilizes angiotensin compounds, either alone or in combination with other growth factors and cytokines.

Career Highlights

Throughout his career, Gere S diZerega has worked with esteemed organizations, including the University of Southern California and Maret Corporation. His work in these institutions has allowed him to collaborate with other professionals in the field and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Kathleen Elizabeth Rodgers and Warren D Sheffield. Their collaborative efforts have furthered the development of innovative solutions in the medical field.

Conclusion

Gere S diZerega's contributions to medical technology through his patents and collaborations highlight his commitment to improving healthcare outcomes. His innovative methods in radiation therapy and cell proliferation continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.